Here, we found that Tandem CAR-T cells could specifically recognize either FOLR1- or MSLN-positive tumor cells and exhibited a superior antitumor effect with a lower E:T ratio than single-target CAR-T cells. This evidence concerns the gene MSLN and neoplasm.